Sotera Health
About: Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.
Employees: 3,000
0
Funds holding %
of 7,139 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
225% more call options, than puts
Call options by funds: $1.16M | Put options by funds: $356K
55% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 56
30% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 30
3% more funds holding
Funds holding: 207 [Q3] → 213 (+6) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 11 [Q3] → 11 (+0) [Q4]
0.36% less ownership
Funds ownership: 93.49% [Q3] → 93.13% (-0.36%) [Q4]
18% less capital invested
Capital invested by funds: $4.42B [Q3] → $3.61B (-$808M) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$17
26%
upside
Avg. target
$17
26%
upside
High target
$17
26%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
Barclays Luke Sergott 31% 1-year accuracy 16 / 52 met price target | 26%upside $17 | Overweight Maintained | 18 Feb 2025 |
Financial journalist opinion
Neutral
GlobeNewsWire
3 days ago
Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2024 before the market opens on Thursday, February 27, 2025. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results.
Neutral
GlobeNewsWire
1 month ago
Sotera Health Chairman and CEO Presents at 43rd Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health's business.
Neutral
GlobeNewsWire
1 month ago
Sotera Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 11:15 a.m. Eastern Time. Mr. Petras, Jon Lyons, Senior Vice President and CFO, and Jason Peterson, Vice President, Investor Relations and Treasurer, will participate in meetings with investors during the conference.
Neutral
GlobeNewsWire
1 month ago
Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director
CLEVELAND, Ohio, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is pleased to announce today the appointment of Vincent K. Petrella as Lead Independent Director, effective January 2, 2025.
Neutral
PRNewsWire
2 months ago
Firstlight Management Calls on the Board of Directors of Sotera Health Company to Launch Sale Process for Nelson Labs
NEW YORK , Dec. 18, 2024 /PRNewswire/ -- On December 3, 2024, Firstlight Management LP sent a letter to the Board of Directors of Sotera Health Company (NASDAQ: SHC) calling for a sale of its Nelson Labs subsidiary. The full text of the letter is as follows: Dear Members of the Board, As you know, Firstlight Management is a Utah-based investment firm founded by an alumnus of Tiger Management and Leonard Green & Partners.
Positive
Benzinga
2 months ago
Top 3 Health Care Stocks That Could Blast Off In December
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Neutral
GlobeNewsWire
3 months ago
Sotera Health to Share Next Chapter of Growth at 2024 Investor Day
CLEVELAND, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, will hold an Investor Day in New York City where Sotera Health's management team will discuss the Company's strategic positioning and outline future growth plans. Management will take questions from a live audience during two question-and-answer sessions.
Neutral
Seeking Alpha
3 months ago
Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Sean Dodge - RBC Capital Markets Patrick Donnelly - Citigroup Inc. Salem Salem - Barclays Brett Fishbin - KeyBanc Capital Markets Casey Woodring - J.P. Morgan Chase Jason Bednar - Piper Sandler Dave Windley - Jefferies Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health Third Quarter 2024 Conference Call.
Neutral
Zacks Investment Research
3 months ago
Sotera Health (SHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Negative
Zacks Investment Research
3 months ago
Sotera Health Company (SHC) Q3 Earnings Lag Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.21 per share a year ago.
Charts implemented using Lightweight Charts™